Correlation Between Enovis Corp and CONMED
Can any of the company-specific risk be diversified away by investing in both Enovis Corp and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enovis Corp and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enovis Corp and CONMED, you can compare the effects of market volatilities on Enovis Corp and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enovis Corp with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enovis Corp and CONMED.
Diversification Opportunities for Enovis Corp and CONMED
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Enovis and CONMED is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Enovis Corp and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and Enovis Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enovis Corp are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of Enovis Corp i.e., Enovis Corp and CONMED go up and down completely randomly.
Pair Corralation between Enovis Corp and CONMED
Given the investment horizon of 90 days Enovis Corp is expected to generate 0.98 times more return on investment than CONMED. However, Enovis Corp is 1.02 times less risky than CONMED. It trades about -0.09 of its potential returns per unit of risk. CONMED is currently generating about -0.1 per unit of risk. If you would invest 4,343 in Enovis Corp on December 28, 2024 and sell it today you would lose (567.00) from holding Enovis Corp or give up 13.06% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Enovis Corp vs. CONMED
Performance |
Timeline |
Enovis Corp |
CONMED |
Enovis Corp and CONMED Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enovis Corp and CONMED
The main advantage of trading using opposite Enovis Corp and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enovis Corp position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.Enovis Corp vs. Helios Technologies | Enovis Corp vs. Enpro Industries | Enovis Corp vs. Omega Flex | Enovis Corp vs. Luxfer Holdings PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |